Alam Firdos Kahn

Title: Alam Firdos Kahn: Innovator in Human Embryonic Stem Cell Research

Introduction

Alam Firdos Kahn is a prominent inventor based in Navi Mumbai, India. He has made significant contributions to the field of biotechnology, particularly in the area of human embryonic stem cell research. His work has implications for regenerative medicine and therapeutic applications.

Latest Patents

Kahn holds a patent for the establishment of a human embryonic stem cell line using mammalian cells. This patent describes purified preparations of human embryonic stem cells that exhibit specific population characteristics. The preparation is characterized by the positive expression of pluripotent cell surface markers such as SSEA-4, TRA-1-60, TRA-1-81, and alkaline phosphatase. Additionally, it includes a set of embryonic stem cell markers like Oct-4, Nanog, and Sox2. The cells are negative for lineage-specific markers, indicating their pluripotent nature. The embryonic stem cell line, named Relicell™ hES1, retains the ability to differentiate into various cell and tissue types derived from all three embryonic germ layers.

Career Highlights

Alam Firdos Kahn is currently associated with Reliance Life Sciences Pvt. Ltd., where he continues to advance his research in stem cell technology. His work has garnered attention for its potential applications in medical science and therapy.

Collaborations

Kahn collaborates with notable colleagues, including Arundhati Mandal and Shabari Pradeep Tipnis, to further enhance the research and development of stem cell applications.

Conclusion

Alam Firdos Kahn's innovative work in human embryonic stem cell research positions him as a key figure in biotechnology. His contributions have the potential to impact various fields, including regenerative medicine and therapeutic development.